Public Health Weekly Report 2022; 15(7): 435-449
Published online February 17, 2022
© The Korea Disease Control and Prevention Agency
Yun-Hee Kim1, Won Hyuk Chang1, Seyoung Shin1, Doo-na Cho1, Deog Young Kim2, Yong Wook Kim2, Dae Hyun Kim2, Ji-hyun Park2, Jongmin Lee3, Hyun-Haeng Lee3, Min Kyun Sohn4, Sung-Ju Jee4, Sam-Gyu Lee5, Min-Keun Song5, Yong-il Shin6, Sung-Hwa Ko6, Ji-Hong Min6, Yang-Soo Lee7, Yu-Sun Min7, Ae-Ryoung Kim7, Min Cheol Joo8, Ji-hee Kim8, Gyung-Jae Oh9, Young-Hoon Lee9, So Young Lee10, Jun Hee Han11, Jeonghoon Ahn12, Soo Mi Choi13, Jeesoo Seo13, Seon Kui Lee13
1Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea
3Department of Rehabilitation Medicine, Konkuk University School of Medicine, Seoul, Korea
4Department of Rehabilitation Medicine, Chungnam National University College of Medicine, Daejeon, Korea
5Department of Physical and Rehabilitation Medicine, Chonnam National University Medical School, Gwangju, Korea
6Department of Rehabilitation Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
7Department of Rehabilitation Medicine, Kyungpook National University School of Medicine, Kyungpook National University Hospital, Daegu, Korea
8Department of Rehabilitation Medicine, Wonkwang University School of Medicine, Iksan, Korea
9Department of Preventive Medicine, Wonkwang University, School of Medicine, Iksan, Korea
10Department of Rehabilitation Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
11Department of Statistics, Hallym University, Chuncheon, Korea
12Department of Health Convergence, Ewha Womans University, Seoul, Korea
13Division of Chronic Disease Prevention, Bureau of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency
The incidence of stroke has increased, and most stroke survivors are left with some degree of residual disability, which places a significant burden on patients, caregivers, and the society. Development of structured stroke care requires long-term assessment of functional outcomes to identify the factors that influence residual disability and quality of life in stroke survivors.
The Korean Stroke Cohort for Functioning and Rehabilitation (KOSCO) is a multi-center, prospective, longitudinal study conducted to investigate the survival and recurrence rates, functional status, mood, and quality of life of patients who have suffered ischemic or hemorrhagic strokes based on face-to-face assessments and interviews. In this study, we also conducted rehabilitation intervention studies to investigate the effects of early intensive rehabilitation therapies on long-term functional outcomes, and analyzed the cost-effectiveness of early intensive rehabilitation therapy in first-ever stroke patients.
Of the 10,636 patients who had suffered their first-ever stroke and who were admitted to 9 hospitals in Korea between August 2012 and May 2015, 7,858 patients agreed to participate in the follow-up study and were enrolled in the 1st Korean Stroke Cohort. The 2nd Korean Stroke Cohort conducted beteween January and December 2020 and included 2,413 patients who agreed to participate in the follow-up study out of the 4,065 patients examined. The clinical and early treatment characteristics of stroke patients differed between the 1st and 2nd Korean Stroke Cohorts, reflecting socio-environmental changes such as aging and medical insurance coverage of stroke care.
Patients in the 2nd Korean Stroke Cohort patients had a significantly higher mean age, higher prevalence of metabolic syndrome and higher previous functional level than those in the 1st Korean Stroke Cohort. In addition the rate of admission to stroke unit increased among patients in the 2nd Korean Stroke Cohort, and the number of patients who received interventional and rehabilitation treatment during the initial hospital reatment increased. Overall, functional outcomes at six months after stroke onset were better in the 2nd Korean Stroke Cohort. In addition, a multiple regression analysis showed that intensive rehabilitation treatment and pneumonia during the initial hospitalization were significant modifiable factors at three months after stroke onset.
These results provide useful information for establishing a comprehensive and structured stroke care system and national policy development for better management of stroke patients.
Key words Stroke, Cohort study, Mortality, Rehabilitation, Functional outcome, Quality of life
| Characteristics | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort |
|---|---|---|
| Ischemic stroke (%) | 77.2% | 76.7% |
| Hemorrhagic stroke (%) | 22.8% | 23.3% |
| Mean age (year) | 65.1±13.5 | 67.0±13.3* |
| Previous functional level, normal (%) | 69.9% | 83.5%* |
| Comorbidity (CCAS ≥8) | 5.13±1.87 | 2.72±1.98* |
*p<0.05
CCAS, Combined condition and age-related score
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort |
|---|---|---|
| Patients admitted to Stroke Unit (%) | 48.9% | 62.7%* |
| Hospital day (day, mean±SD) | 18.0±23.2 | 15.1±27.6* |
| Consultation for Rehabilitation (%) | 75.1% | 85.7%* |
| Consultation for Rehabilitation (day) | 2.7±5.6 | 2.1±4.7* |
| Transfer to Rehabilitation department (%) | 16.5% | 19.7%* |
| Transfer to Rehabilitation department (day) | 16.8±14.8 | 13.4±13.7* |
*p<0.05
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort | ||
|---|---|---|---|---|
| β | (p-value) | β | (p-value) | |
| Age | -0.268 | <0.001* | -0.162 | <0.001* |
| Alcohol | 1.308 | 0.014* | - | |
| CCAS | - | -0.050 | 0.035* | |
| Premorbid mRS | 0.761 | <0.001* | 0.636 | 0.003* |
| 7 day stroke severity (NIHSS) | - | -1.314 | 0.004* | |
| 7 day cognitive function (K-MMSE) | -1.706 | <0.001* | -0.552 | 0.007* |
| 7 day motor function (FMA) | 0.173 | <0.001* | 0.258 | <0.001* |
| 7 day ambulatory function (FAC) | 0.273 | <0.001* | 2.371 | <0.001* |
| 7 day swallowing fucntion (AHSA-NOMS) | 1.120 | <0.001* | - | |
| 7 day language function (K-FAST-SF) | - | 0.349 | 0.006* | |
| Pneumonia | -7.226 | 0.002* | -17.710 | <0.001* |
| Urinary tract infection | -8.860 | <0.001* | - | |
| Initial hospitalization days | -0.127 | <0.001* | - | |
| Intensive rehabilitation treatment | 5.357 | <0.001* | 4.188 | 0.002* |
*p<0.05
CCAS, Combined condition and age-related score; mRS. modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FMA, Fugl-Meyer Assessment; FAC, Functional Ambulatory Categories; ASHA-NOMS, Speech-Language-Hearing Association National Outcome Measurement System; K-FAST-SF, Korean version of Frenchay Aphasia Screening Test Short Form
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort | ||
|---|---|---|---|---|
| β | (p-value) | β | (p-value) | |
| Age | -0.465 | <0.001* | -0.466 | <0.001* |
| Premorbid mRS | 1.205 | 0.018* | - | |
| 7 day stroke severity (NIHSS) | -0.822 | <0.001* | - | |
| 7 day motor function (FMA) | 0.205 | <0.001* | 0.390 | <0.001* |
| 7 day ambulatory function (FAC) | - | 2.279 | <0.001* | |
| 7 day swallowing fucntion (AHSA-NOMS) | 1.518 | <0.001* | - | |
| Pneumonia | -11.316 | 0.002* | -73.613 | <0.001* |
| Respiratory failure | -18.802 | 0.003- | - | |
| Initial hospitalization days | -0.151 | <0.001* | - | |
*p<0.05
mRS. modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FMA, Fugl-Meyer Assessment; FAC, Functional Ambulatory Categories; ASHA-NOMS, Speech-Language-Hearing Association National Outcome Measurement System
Public Health Weekly Report 2022; 15(7): 435-449
Published online February 17, 2022
Copyright © The Korea Disease Control and Prevention Agency.
Yun-Hee Kim1, Won Hyuk Chang1, Seyoung Shin1, Doo-na Cho1, Deog Young Kim2, Yong Wook Kim2, Dae Hyun Kim2, Ji-hyun Park2, Jongmin Lee3, Hyun-Haeng Lee3, Min Kyun Sohn4, Sung-Ju Jee4, Sam-Gyu Lee5, Min-Keun Song5, Yong-il Shin6, Sung-Hwa Ko6, Ji-Hong Min6, Yang-Soo Lee7, Yu-Sun Min7, Ae-Ryoung Kim7, Min Cheol Joo8, Ji-hee Kim8, Gyung-Jae Oh9, Young-Hoon Lee9, So Young Lee10, Jun Hee Han11, Jeonghoon Ahn12, Soo Mi Choi13, Jeesoo Seo13, Seon Kui Lee13
1Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea
3Department of Rehabilitation Medicine, Konkuk University School of Medicine, Seoul, Korea
4Department of Rehabilitation Medicine, Chungnam National University College of Medicine, Daejeon, Korea
5Department of Physical and Rehabilitation Medicine, Chonnam National University Medical School, Gwangju, Korea
6Department of Rehabilitation Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
7Department of Rehabilitation Medicine, Kyungpook National University School of Medicine, Kyungpook National University Hospital, Daegu, Korea
8Department of Rehabilitation Medicine, Wonkwang University School of Medicine, Iksan, Korea
9Department of Preventive Medicine, Wonkwang University, School of Medicine, Iksan, Korea
10Department of Rehabilitation Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
11Department of Statistics, Hallym University, Chuncheon, Korea
12Department of Health Convergence, Ewha Womans University, Seoul, Korea
13Division of Chronic Disease Prevention, Bureau of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency
The incidence of stroke has increased, and most stroke survivors are left with some degree of residual disability, which places a significant burden on patients, caregivers, and the society. Development of structured stroke care requires long-term assessment of functional outcomes to identify the factors that influence residual disability and quality of life in stroke survivors.
The Korean Stroke Cohort for Functioning and Rehabilitation (KOSCO) is a multi-center, prospective, longitudinal study conducted to investigate the survival and recurrence rates, functional status, mood, and quality of life of patients who have suffered ischemic or hemorrhagic strokes based on face-to-face assessments and interviews. In this study, we also conducted rehabilitation intervention studies to investigate the effects of early intensive rehabilitation therapies on long-term functional outcomes, and analyzed the cost-effectiveness of early intensive rehabilitation therapy in first-ever stroke patients.
Of the 10,636 patients who had suffered their first-ever stroke and who were admitted to 9 hospitals in Korea between August 2012 and May 2015, 7,858 patients agreed to participate in the follow-up study and were enrolled in the 1st Korean Stroke Cohort. The 2nd Korean Stroke Cohort conducted beteween January and December 2020 and included 2,413 patients who agreed to participate in the follow-up study out of the 4,065 patients examined. The clinical and early treatment characteristics of stroke patients differed between the 1st and 2nd Korean Stroke Cohorts, reflecting socio-environmental changes such as aging and medical insurance coverage of stroke care.
Patients in the 2nd Korean Stroke Cohort patients had a significantly higher mean age, higher prevalence of metabolic syndrome and higher previous functional level than those in the 1st Korean Stroke Cohort. In addition the rate of admission to stroke unit increased among patients in the 2nd Korean Stroke Cohort, and the number of patients who received interventional and rehabilitation treatment during the initial hospital reatment increased. Overall, functional outcomes at six months after stroke onset were better in the 2nd Korean Stroke Cohort. In addition, a multiple regression analysis showed that intensive rehabilitation treatment and pneumonia during the initial hospitalization were significant modifiable factors at three months after stroke onset.
These results provide useful information for establishing a comprehensive and structured stroke care system and national policy development for better management of stroke patients.
Keywords: Stroke, Cohort study, Mortality, Rehabilitation, Functional outcome, Quality of life
| Characteristics | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort |
|---|---|---|
| Ischemic stroke (%) | 77.2% | 76.7% |
| Hemorrhagic stroke (%) | 22.8% | 23.3% |
| Mean age (year) | 65.1±13.5 | 67.0±13.3* |
| Previous functional level, normal (%) | 69.9% | 83.5%* |
| Comorbidity (CCAS ≥8) | 5.13±1.87 | 2.72±1.98* |
*p<0.05.
CCAS, Combined condition and age-related score.
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort |
|---|---|---|
| Patients admitted to Stroke Unit (%) | 48.9% | 62.7%* |
| Hospital day (day, mean±SD) | 18.0±23.2 | 15.1±27.6* |
| Consultation for Rehabilitation (%) | 75.1% | 85.7%* |
| Consultation for Rehabilitation (day) | 2.7±5.6 | 2.1±4.7* |
| Transfer to Rehabilitation department (%) | 16.5% | 19.7%* |
| Transfer to Rehabilitation department (day) | 16.8±14.8 | 13.4±13.7* |
*p<0.05.
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort | ||
|---|---|---|---|---|
| β | (p-value) | β | (p-value) | |
| Age | -0.268 | <0.001* | -0.162 | <0.001* |
| Alcohol | 1.308 | 0.014* | - | |
| CCAS | - | -0.050 | 0.035* | |
| Premorbid mRS | 0.761 | <0.001* | 0.636 | 0.003* |
| 7 day stroke severity (NIHSS) | - | -1.314 | 0.004* | |
| 7 day cognitive function (K-MMSE) | -1.706 | <0.001* | -0.552 | 0.007* |
| 7 day motor function (FMA) | 0.173 | <0.001* | 0.258 | <0.001* |
| 7 day ambulatory function (FAC) | 0.273 | <0.001* | 2.371 | <0.001* |
| 7 day swallowing fucntion (AHSA-NOMS) | 1.120 | <0.001* | - | |
| 7 day language function (K-FAST-SF) | - | 0.349 | 0.006* | |
| Pneumonia | -7.226 | 0.002* | -17.710 | <0.001* |
| Urinary tract infection | -8.860 | <0.001* | - | |
| Initial hospitalization days | -0.127 | <0.001* | - | |
| Intensive rehabilitation treatment | 5.357 | <0.001* | 4.188 | 0.002* |
*p<0.05.
CCAS, Combined condition and age-related score; mRS. modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FMA, Fugl-Meyer Assessment; FAC, Functional Ambulatory Categories; ASHA-NOMS, Speech-Language-Hearing Association National Outcome Measurement System; K-FAST-SF, Korean version of Frenchay Aphasia Screening Test Short Form.
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort | ||
|---|---|---|---|---|
| β | (p-value) | β | (p-value) | |
| Age | -0.465 | <0.001* | -0.466 | <0.001* |
| Premorbid mRS | 1.205 | 0.018* | - | |
| 7 day stroke severity (NIHSS) | -0.822 | <0.001* | - | |
| 7 day motor function (FMA) | 0.205 | <0.001* | 0.390 | <0.001* |
| 7 day ambulatory function (FAC) | - | 2.279 | <0.001* | |
| 7 day swallowing fucntion (AHSA-NOMS) | 1.518 | <0.001* | - | |
| Pneumonia | -11.316 | 0.002* | -73.613 | <0.001* |
| Respiratory failure | -18.802 | 0.003- | - | |
| Initial hospitalization days | -0.151 | <0.001* | - | |
*p<0.05.
mRS. modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FMA, Fugl-Meyer Assessment; FAC, Functional Ambulatory Categories; ASHA-NOMS, Speech-Language-Hearing Association National Outcome Measurement System.
| Characteristics | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort |
|---|---|---|
| Ischemic stroke (%) | 77.2% | 76.7% |
| Hemorrhagic stroke (%) | 22.8% | 23.3% |
| Mean age (year) | 65.1±13.5 | 67.0±13.3* |
| Previous functional level, normal (%) | 69.9% | 83.5%* |
| Comorbidity (CCAS ≥8) | 5.13±1.87 | 2.72±1.98* |
*p<0.05.
CCAS, Combined condition and age-related score.
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort |
|---|---|---|
| Patients admitted to Stroke Unit (%) | 48.9% | 62.7%* |
| Hospital day (day, mean±SD) | 18.0±23.2 | 15.1±27.6* |
| Consultation for Rehabilitation (%) | 75.1% | 85.7%* |
| Consultation for Rehabilitation (day) | 2.7±5.6 | 2.1±4.7* |
| Transfer to Rehabilitation department (%) | 16.5% | 19.7%* |
| Transfer to Rehabilitation department (day) | 16.8±14.8 | 13.4±13.7* |
*p<0.05.
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort | ||
|---|---|---|---|---|
| β | (p-value) | β | (p-value) | |
| Age | -0.268 | <0.001* | -0.162 | <0.001* |
| Alcohol | 1.308 | 0.014* | - | |
| CCAS | - | -0.050 | 0.035* | |
| Premorbid mRS | 0.761 | <0.001* | 0.636 | 0.003* |
| 7 day stroke severity (NIHSS) | - | -1.314 | 0.004* | |
| 7 day cognitive function (K-MMSE) | -1.706 | <0.001* | -0.552 | 0.007* |
| 7 day motor function (FMA) | 0.173 | <0.001* | 0.258 | <0.001* |
| 7 day ambulatory function (FAC) | 0.273 | <0.001* | 2.371 | <0.001* |
| 7 day swallowing fucntion (AHSA-NOMS) | 1.120 | <0.001* | - | |
| 7 day language function (K-FAST-SF) | - | 0.349 | 0.006* | |
| Pneumonia | -7.226 | 0.002* | -17.710 | <0.001* |
| Urinary tract infection | -8.860 | <0.001* | - | |
| Initial hospitalization days | -0.127 | <0.001* | - | |
| Intensive rehabilitation treatment | 5.357 | <0.001* | 4.188 | 0.002* |
*p<0.05.
CCAS, Combined condition and age-related score; mRS. modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FMA, Fugl-Meyer Assessment; FAC, Functional Ambulatory Categories; ASHA-NOMS, Speech-Language-Hearing Association National Outcome Measurement System; K-FAST-SF, Korean version of Frenchay Aphasia Screening Test Short Form.
| Factors | 1st Korean Stroke Cohort | 2nd Korean Stroke Cohort | ||
|---|---|---|---|---|
| β | (p-value) | β | (p-value) | |
| Age | -0.465 | <0.001* | -0.466 | <0.001* |
| Premorbid mRS | 1.205 | 0.018* | - | |
| 7 day stroke severity (NIHSS) | -0.822 | <0.001* | - | |
| 7 day motor function (FMA) | 0.205 | <0.001* | 0.390 | <0.001* |
| 7 day ambulatory function (FAC) | - | 2.279 | <0.001* | |
| 7 day swallowing fucntion (AHSA-NOMS) | 1.518 | <0.001* | - | |
| Pneumonia | -11.316 | 0.002* | -73.613 | <0.001* |
| Respiratory failure | -18.802 | 0.003- | - | |
| Initial hospitalization days | -0.151 | <0.001* | - | |
*p<0.05.
mRS. modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FMA, Fugl-Meyer Assessment; FAC, Functional Ambulatory Categories; ASHA-NOMS, Speech-Language-Hearing Association National Outcome Measurement System.
Dae Hyun Kim, Deog Young Kim, Jongmin Lee, Min Kyun Sohn, Min-Keun Song, Yong-Il Shin, Yang-Soo Lee, Min Cheol Joo, So Young Lee, Jeonghoon Ahn, Gyung-Jae Oh, Young Hoon Lee, Junhee Han, Ho Seok Lee, Doona Cho, Young-Taek Kim, Yun-Hee Kim, Won Hyuk Chang
Public Health Weekly Report 2024; 17(42): 1767-1785 https://doi.org/10.56786/PHWR.2024.17.42.1Sung Eun Lee, Min Kim, Ji Man Hong, Seung Hee Lee, Sang-Moon Yun, Won-Ho Kim
Public Health Weekly Report 2021; 14(49): 3495-3501 https://doi.org/10.56786/phwr.2021.14.49.3495Mi-sun Oh, Minwoo Lee and Kyung-Ho Yu, Sang-Moon Yun, Won-Ho Kim
Public Health Weekly Report 2021; 14(40): 2822-2830 https://doi.org/10.56786/phwr.2021.14.40.2822